Evolent Health Inc Class A (EVH)
$4.80
$0.22
(4.80%)
As on 12-Jun-2026 16:28EDT
Market cap
$517 Mln
Revenue (TTM)
$1,889 Mln
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-507 Mln
-
ROE
-0.7 %
-
ROCE
-- %
-
Industry P/E
50.52
-
EV/EBITDA
88.5
-
Debt to Equity
2.5
-
Book Value
$--
-
EPS
$-4.4
-
Face value
--
-
Shares outstanding
112,481,067
10 Years Aggregate
CFO
$-68.14 Mln
EBITDA
$-324.46 Mln
Net Profit
$-767.67 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Evolent Health Inc Class A (EVH)
| 20.0 | 21.2 | 58.9 | -44.4 | -46.6 | -24.4 | -11.3 |
|
BSE Sensex*
| -9.9 | 1.1 | 2.3 | -6.0 | 6.4 | 7.7 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Evolent Health Inc Class A (EVH)
| -64.4 | -65.6 | 17.6 | 1.5 | 72.6 | 77.1 | -54.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Evolent Health Inc Class A (EVH)
|
4.8 | 517.4 | 1,888.8 | -496.5 | -22.9 | -80.2 | -- | 1.3 |
| 88.2 | 153,593.1 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 24.7 | 3.0 | |
| 46.9 | 70,111.4 | 20,615.0 | 3,553.0 | 19.9 | 14.5 | 19.7 | 2.8 | |
| 180.1 | 127,957.8 | 24,778.0 | 3,689.0 | 18.5 | 7.1 | 35.1 | 2.4 | |
| 85.1 | 49,006.3 | 6,303.5 | 1,092.8 | 12.7 | 10.6 | 46 | 4.8 | |
| 560.9 | 44,243.9 | 4,446.1 | 1,095.2 | 31.7 | 70.3 | 41.3 | 28.4 | |
| 411.1 | 145,582.2 | 10,582.1 | 2,979.1 | 25.0 | 17.2 | 50 | 8.3 | |
| 80.2 | 103,134.5 | 36,364.0 | 4,800.0 | 13.3 | 19.6 | 21.5 | 2.1 | |
| 312.2 | 117,170.4 | 25,270.0 | 3,337.0 | 18.7 | 15.1 | 35.3 | 5.1 | |
| 469.3 | 176,765.5 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 26.2 | 3.4 |
Shareholding Pattern
View DetailsAbout Evolent Health Inc Class A (EVH)
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan... administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. Read more
-
Co-Founder, CEO & Director
Mr. Seth Barrie Blackley
-
President
Mr. Dan McCarthy
-
Headquarters
Arlington, VA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Evolent Health Inc Class A (EVH)
What is the current share price of Evolent Health Inc Class A (EVH) Today?
The share price of Evolent Health Inc Class A (EVH) is $4.80 (NYSE) as of 12-Jun-2026 16:28 EDT. Evolent Health Inc Class A (EVH) has given a return of -46.59% in the last 3 years.
What is the current PB & PE ratio of Evolent Health Inc Class A (EVH)?
Since, TTM earnings of Evolent Health Inc Class A (EVH) is negative, P/E ratio is not available.
The P/B ratio of Evolent Health Inc Class A (EVH) is 1.30 times as on 12-Jun-2026, a 61 discount to its peers’ median range of 3.37 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.85
|
1.10
|
|
2024
|
-21.00
|
1.29
|
|
2023
|
-33.19
|
3.51
|
|
2022
|
-146.23
|
3.26
|
|
2021
|
-65.00
|
3.52
|
What is the 52 Week High and Low of Evolent Health Inc Class A (EVH)?
The 52-week high and low of Evolent Health Inc Class A (EVH) are Rs 12.07 and Rs 2.10 as of 15-Jun-2026.
What is the market cap of Evolent Health Inc Class A (EVH)?
Evolent Health Inc Class A (EVH) has a market capitalisation of $ 517 Mln as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Evolent Health Inc Class A (EVH)?
Before investing in Evolent Health Inc Class A (EVH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.